GSK's Reilly, Two Local Executives Of China Unit Charged With Bribery
This article was originally published in PharmAsia News
Executive Summary
Mark Reilly, the British head of GlaxoSmithKline's China unit when it sparked an anti-corruption campaign nearly a year ago has been charged by police of masterminding the bribing of China officials and others.